Answers are grounded in this paper and cite their sources.
Protein-supported nanoparticles have a great significance in scientific and nanotechnology research because of their “green” process, low cost-in-use, good biocompatibility, and some interesting properties. Ruthenium oxide nanoparticles (RuO 2 NPs) have been considered to be an important member in nanotechnology research. However, the biosynthetic approach of RuO 2 NPs is relatively few compared to those of other nanoparticles. To address this challenge, this work presented a new way for RuO 2 NP synthesis (BSA-RuO 2 NPs) supported by bovine serum albumin (BSA). BSA-RuO 2 NPs are confirmed to exert peroxidase-like activity, electrocatalytic activity, in vitro salt resistance (2 M NaCl), and biocompatibility. Results indicate that BSA-RuO 2 NPs have higher affinity binding for 3,3′,5,5′-tetramethylbenzidine or H 2 O 2 than bare RuO 2 NPs. Moreover, BSA turns out to be a crucial factor in promoting the stability of RuO 2 NPs. Taking the advantages of these improved properties, we established colorimetric (linear range from 2 to 800 μM, a limit of detection of 1.8 μM) and electrochemical (linear range from 0.4 to 3850 μM, a limit of detection of 0.18 μM) biosensors for monitoring in situ H 2 O 2 secretion from living MCF-7 cells. Herein, this work offers a new biosynthesis strategy to obtain BSA-RuO 2 NPs and sheds light on the sensitive biosensors to monitor the H 2 O 2 secreted from living cells for promising applications in the fields of nanotechnology, biology, biosensors, and medicine.
No takes yet. Share an insight, caveat, or question.
He et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: